Company
tempesttx
Tempest is a clinical-stage CAR-T company building the future of in vivo CAR-T therapy with broad potential benefit for patients with autoimmune diseases or cancer
Also known as Tempest Therapeutics, Tempest Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Tempest Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Tempest Therapeutics is a clinical-stage biotechnology company focused on pioneering a pipeline of next generation in vivo CAR-T cell therapies for autoimmune and oncology indications.
Products
- Other
- TPST-2003
- Other
- TPST-4003
Loading relationship preview